Histone deacetylase inhibitors suppress mutant p53 transcription via HDAC8/YY1 signals in triple negative breast cancer cells

Cellular Signalling
Zhao-Tong WangHong-Sheng Wang

Abstract

There is an urgent need to investigate the potential targeted therapy approach for triple-negative breast cancer (TNBC). Our present study reveals that histone deacetylase inhibitors (HDACIs) suberoyl anilide hydroxamic acid (SAHA) and sodium butyrate (NaB) significantly inhibit cell proliferation, arrest cell cycle at G0/G1 phase, and induce mitochondrial related apoptosis of TNBC cells. Further, SAHA and NaB decrease the phosphorylation, protein and mRNA levels of mutant p53 (mtp53) in TNBC cells. While SAHA or NaB has no similar inhibition effect on wild type p53 (wtp53). The inhibition apparently occurs at the level of transcription because the down regulation of precursor p53 transcription is much more rapid (less than 2h) and sharp than that of mature p53. The knockdown of HDAC8, while not HDAC6, inhibits the transcription of mtp53 in TNBC cells. The luciferase assay and ChIP analysis reveal that both SAHA and NaB can reduce the binding of transcription factor Yin Yang 1 (YY1) with the -102 to -96 position of human p53 promoter. Knockdown of YY1 also significantly inhibits the transcription of mtp53 in TNBC cells. Further, SAHA and NaB can inhibit the association of HDAC8 and YY1, increase acetylation of residues 170-200 ...Continue Reading

References

Aug 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·V M RichonP A Marks
Aug 4, 2001·Molecular and Cellular Biology·Y L YaoE Seto
Nov 18, 2005·Gene·Michele A GlozakEdward Seto
Dec 7, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Owen A O'ConnorWilliam K Kelly
Feb 21, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Magali OlivierAnne-Lise Børresen-Dale
Sep 7, 2006·Nature Reviews. Drug Discovery·Jessica E BoldenRicky W Johnstone
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rebecca DentSteven A Narod
Nov 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Thehang H LuuGeorge Somlo
Dec 24, 2008·Cancer Letters·Wilko Weichert
Dec 30, 2008·Cancer Letters·Leigh EllisRoberto Pili
Jan 2, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ina OehmeOlaf Witt
Mar 5, 2009·The Journal of Biological Chemistry·Wensheng Yan, Xinbin Chen
Aug 21, 2009·Nature Reviews. Cancer·Ran Brosh, Varda Rotter
Mar 10, 2010·The Journal of Biological Chemistry·Wensheng Yan, Xinbin Chen
Mar 30, 2011·Nature Chemical Biology·Jie XuJoost Schymkowitz
Jun 3, 2011·The Journal of Clinical Investigation·Brian D LehmannJennifer A Pietenpol
Aug 5, 2011·Epigenetics : Official Journal of the DNA Methylation Society·Ricardo Saldaña-Meyer, Félix Recillas-Targa
Mar 1, 2012·International Journal of Cancer. Journal International Du Cancer·Seung Hyun OhHo-Young Lee
Mar 24, 2012·The American Journal of Pathology·Meimei WanGuangchao Sui
Jun 21, 2012·Genes & Development·William A Freed-Pastor, Carol Prives
Jul 24, 2012·Carcinogenesis·Dawid WalerychGiannino Del Sal
Dec 25, 2012·Nature Cell Biology·Patricia A J Muller, Karen H Vousden
Jan 17, 2013·Cancer Treatment Reviews·Natalie TurnerAngelo Di Leo
Apr 29, 2014·Pharmacology & Therapeutics·Prithviraj BoseSteven Grant
Jun 6, 2014·Cellular and Molecular Life Sciences : CMLS·Jing Zhang, Qing Zhong

❮ Previous
Next ❯

Citations

Nov 14, 2016·Cellular Signalling·Claudia SchäferOliver H Krämer
May 12, 2017·Cell Death & Disease·Xu FengWuguo Deng
Dec 14, 2018·International Journal of Molecular Sciences·Maria MrakovcicLeopold F Fröhlich
Dec 7, 2018·Journal of Molecular Cell Biology·Xiang ZhouHua Lu
Aug 31, 2017·International Journal of Molecular Sciences·Maria MrakovcicLeopold F Fröhlich
Dec 25, 2019·Signal Transduction and Targeted Therapy·Yuan ChengXiawei Wei
Jul 20, 2020·Journal of Experimental & Clinical Cancer Research : CR·Rui ChenYali Wang
Apr 15, 2019·Cellular and Molecular Life Sciences : CMLS·Srimanta PatraSujit K Bhutia
Oct 6, 2020·Frontiers in Cell and Developmental Biology·Marco SpreaficoAnna Pistocchi
Oct 3, 2018·Journal of breast cancer·Daiana Cosmina TemianIoana Berindan-Neagoe
Nov 27, 2020·Frontiers in Oncology·Gaoyang ZhuXuemei Fu
Dec 4, 2020·International Journal of Molecular Sciences·Yuxiang Luo, Huilin Li
Dec 17, 2020·Signal Transduction and Targeted Therapy·Yuan ChengXiawei Wei
Mar 11, 2021·Pathology, Research and Practice·Golebagh RahmaniRezvan Najafi
Apr 10, 2021·Journal of Natural Products·Shumpei NemotoHiroyuki Kusuhara
May 2, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Sheng YangMei Dong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.